Theravent honored with GOOD DESIGN Award for snoring therapy

Theravent, Inc., a medical device company providing noninvasive solutions for people with sleep disordered breathing, has been honored with a GOOD DESIGN™ Award in the medical category for the design of its product, Theravent™ Advanced Nightly Snore Therapy.

The prominent awards program is organized annually by The Chicago Athenaeum Museum of Architecture and Design in cooperation with the European Centre for Architecture, Art, Design and Urban Studies to honor the most innovative industrial, product and graphic designs produced internationally.

"Snoring is an age-old problem, but Theravent is a new, easy-to-use and effective design that scientifically treats snoring and provides quiet, uninterrupted nights for snorers and their bed partners," said Theravent, Inc. CEO Matthew Williams. "We are very excited to have our product included on this notable list among the most cutting-edge designs around the world."

Theravent is an over-the-counter FDA-cleared treatment used to reduce or eliminate snoring using Expiratory Positive Airway Pressure (EPAP) therapy, a technology also contained in the company's prescription sleep apnea treatment, Provent. It features MicroValve technology, which attaches to and covers the nostrils to create pressure during exhalation, keeping a person's airway open while they sleep and preventing sleep disordered breathing and snoring.

Theravent was rigorously tested in three clinical trials. The results, published in Sleep Diagnosis and Therapy, showed that it reduced snoring by an average of 76 percent for successful users and approximately three out of four bed partners got a better night's sleep when their partner used Theravent.  Since 2009, more than five million nights of EPAP therapy have been provided to OSA patients using Provent and snoring patients using Theravent.